doi:10.16150/j.1671-2870.2017.06.001

[1] Kearney PM, Whelton M, Reynolds K, et al.Global burden of hypertension: analysis of worldwide data[J]. Lancet,2005,365(9455):217-223.
[2] McAdam-Marx C, Ye X, Sung JC, et al. Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting[J]. Clin Ther,2009,31(5):1116-1123.
[3] Krum H, Schlaich M, Whitbourn R, et al.Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study[J]. Lancet,2009,373(9671):1275-1281.
[4] Krum H, Schlaich MP, Sobotka PA, et al.Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study[J]. Lancet,2014,383(9917):622-629.
[5] Esler MD, Krum H, Schlaich M, et al.Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial[J]. Circulation,2012,126(25):2976-2982.
[6] Esler MD, Böhm M, Sievert H, et al.Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial[J]. Eur Heart J,2014,35(26):1752-1759.
[7] Bhatt DL, Kandzari DE, O'Neill WW, et al. A controlled trial of renal denervation for resistant hypertension[J]. N Engl J Med,2014,370(15):1393-1401.
[8] 蒋雄京, 高润霖. SIMPLICITY HTN 3研究后时代:去肾神经术治疗难治性高血压的现状与挑战[J]. 中华医学杂志,2014,94(23):1761-1763.
[9] Persu A, Jin Y, Fadl Elmula FE, et al.Renal denervation after Symplicity HTN-3: an update[J]. Curr Hypertens Rep,2014,16(8):460.
[10] 蒋雄京, 董徽. SYMPLICITY HTN-3结果阴性不能否定经导管肾神经消融理念[J]. 中国循环杂志,2014,29(6):404-405.
[11] Esler M.Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings[J]. J Am Soc Hypertens,2014,8(8):593-598.
[12] Böhm M, Mahfoud F, Ukena C, et al.First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension[J]. Hypertension,2015,65(4):766-774.
[13] Townsend RR, Mahfoud F, Kandzari DE, et al.Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial[J]. Lancet,2017,390(10108):2160-2170.
[14] 董徽, 蒋雄京. 去肾神经仍是治疗难治性高血压有希望的方法[J]. 中华高血压杂志,2014,22(11):1018-1020.
[15] 蒋雄京, 熊洪亮. 去肾交感神经术治疗高血压的再思考与阜外经验[J]. 心脑血管病防治,2016,16(5):329-332.
[16] Fengler K, Ewen S, Höllriegel R, et al.Blood pressure response to main renal artery and combined main renal artery plus branch renal denervation in patients with resistant hypertension[J]. J Am Heart Assoc,2017,6(8):e006196.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 460-468.
[2]	CHENG Yibang, LI Mingxuan, CHEN Bo, CAO Sheng, JIANG Gonghao, XU Jianzhong, LI Yan, WANG Jiguang. Diagnostic value of measuring the plasma renin and aldosterone by chemiluminescence immunoassay in the primary aldosteronism [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 474-480.
[3]	LI Zhoutong, ZHANG Wei, WANG Jiguang. Accuracy of home versus ambulatory blood pressure monitoring in the diagnosis of white-coat and masked hypertension [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 487-493.
[4]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 525-527.
[5]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 528-530.
[6]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 445-449.
[7]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 450-453.
[8]	. [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(05): 454-459.
[9]	HUANG Yongyan, YANG Lina, CAO Jiumei, WANG Wei. Cloud-based solution assisted blood pressure management in outpatient setting [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(03): 319-324.
[10]	WANG Yajuan, GUO Qianhui, ZHANG Dongyan, CHENG Yibang, CHEN Ling, ZHU Dingliang, LI Yan. Prevalence of overweight and obesity and analysis of blood pressure related factors among children and adolescents in Xinzhuang community, Shanghai [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(05): 575-580.
[11]	HUANG Jianfeng, SHENG Changsheng, HUANG Qifang, CHENG Yibang, GUO Qianhui, ZHANG Dongyan, WANG Jiguang, LI Yan. Study on circadian blood pressure rhythmandrelated influencing factors in outpatients [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(03): 313-318.
[12]	WEI Jian, GAO Pingjin, HAN Weiqing. Effect of α7 nicotinic acetylcholine receptor activation on transforming growth factor β1-induced phenotypic transformation of adventitia fibroblasts studied in vitro [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(1): 56-60.
[13]	GUO Tongshuai, CHU Chao, WANG Yang, REN Keyu, MU Jianjun. Effects of salt loading and potassium supplement on circadian blood pressure profile in salt-sensitive Chinese subjects [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(06): 582-586.
[14]	CHEN Hui, GUO Qianhui, XU Jie, CHENG Yibang, ZHANG Dongyan, WANG Ying, HUANG Qifang, SHENG Changsheng, LI Yan. Prevalence and determinants of asymptomatic intracranial artery stenosis assessed by transcranial Doppler ultrosonography [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(06): 592-595.
[15]	. [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(06): 576-581.